Position in ABBV
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$495,062,192
+$134,458,553 QoQ
Shares Held
1,967,343
+18.7% QoQ
Ownership
0.111%
of shares outstanding
% of Portfolio
0.82%
of 13F equity value
Holder Rank
#82
of 4,138 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Derivatives in ABBV
reported options exposure · as of Sep 30, 2024CallValue
$0
CallShares
0
PutValue
$180
PutShares
100
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HighTower Advisors, LLC holds $4,788,622,872 across 16 Drug Manufacturers - General names. ABBV ranks #3 (10.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
9,892,767 | $2,512,466,034 | |
| 2 | LLY |
ELI LILLY & Co
|
436,561 | $523,624,403 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
1,967,343 | $495,062,192 | |
| 4 | MRK |
Merck & Co., Inc.
|
3,679,920 | $472,869,720 | |
| 5 | AMGN |
Amgen Inc
|
816,257 | $295,582,984 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,534,627 | $193,884,775 | |
| 7 | AZN |
Astrazeneca PLC
|
455,278 | $86,329,814 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,126,721 | $64,921,664 |
All Filings in ABBV
Export CSV
32 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $495,062,192 | 1,967,343 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $360,603,639 | 1,658,024 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $372,189,874 | 1,628,911 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $380,138,667 | 1,641,784 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $295,268,147 | 1,590,713 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $331,116,398 | 1,580,357 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $279,669,413 | 1,573,829 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $290,988,952 | 1,473,511 | Shares | Sole | 2024-11-14 | |
| 2024-09-30 | $180 | 100 | Put | Sole | 2024-11-14 | |
| 2024-06-30 | $246,165,675 | 1,435,201 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $127,520 | 34,500 | Call | Sole | 2024-05-06 | |
| 2024-03-31 | $266,164,279 | 1,461,638 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $238,396,084 | 1,538,337 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $229,687,150 | 1,540,904 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $177,671,280 | 1,318,721 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $211,371,474 | 1,326,294 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $222,046,322 | 1,373,964 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $174,906,229 | 1,303,228 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $199,491,665 | 1,302,505 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $2,593 | 16 | Call | Sole | 2022-05-12 | |
| 2022-03-31 | $220,154,620 | 1,358,057 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $183,972,177 | 1,358,731 | Shares | Sole | 2022-02-10 | |
| 2021-12-31 | $2,031 | 15 | Put | Sole | 2022-02-10 | |
| 2021-09-30 | $139,573,640 | 1,293,906 | Shares | Sole | 2021-11-12 | |
| 2021-09-30 | $1,000 | 800 | Put | Sole | 2021-11-12 | |
| 2021-06-30 | $33,792 | 300 | Call | Sole | 2021-08-06 | |
| 2021-06-30 | $142,909,972 | 1,268,732 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $122,415,109 | 1,131,169 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $118,721,449 | 1,107,993 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $88,853,310 | 1,014,423 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $90,029,096 | 916,980 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $63,546,955 | 834,059 | Shares | Sole | 2020-05-21 | |
| No filing history on record for this holder in this stock. | ||||||